Audubon, PA and London (PRWEB) November 21, 2014
Two new educational webinars hosted by DrugDev in December will explore what comes next for ALS research and how the pharmaceutical industry can make life easier for clinical sites.
After the Ice Bucket Challenge: Where Does the ALS Money Go?
Featuring guest speaker Dr. Merit Cudkowicz
Date: Tuesday, 2 December 2014
Time: 1:30pm ET
Register to attend
This webinar is complimentary
Join expert speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology at Massachusetts General Hospital at Harvard Medical School, for an interactive discussion which will provide an overview of ALS, current treatment options and future prospects in research and drug development.
Making Clinical Trials Less of a Trial for Investigators: Results from a Global Investigator Survey
Presented by the Society for Clinical Research Sites (SCRS)
Date: Tuesday, 9 December 2014
Time: 12:00pm ET
Register to attend
This webinar is complimentary for SCRS members, $79 for non-members
Hosted by Dr. Claire Sears, Director of Investigator Engagement at DrugDev, the webinar will present results from a large scale survey of 750 investigators in Argentina, Australia, Germany, India, South Africa, the United Kingdom, and the United States. Attendees will get a clear view into the realities of what investigators report to be the burdens of clinical trial operations which contribute to high investigator turnover and make site sustainability a challenge for all involved in clinical research. Dr. Sears will discuss solutions investigators have identified to address these issues and how the pharma industry can achieve the dual goals of reducing investigator burden and realizing cost and efficiency gains.
About DrugDev
DrugDev is a family of technology driven solutions that help investigators, sponsors and CROs do more trials together. DrugDev combines innovative solutions for global site selection, study startup, investigator payments and data hosting with an award-winning clinical operations platform (powered by TrialNetworks) to enable faster, cheaper and higher quality trials. DrugDev also serves as the trusted third-party host of the Investigator Databank, a pre-competitive collaboration between Jannsen, Merck, Lilly, Pfizer and Novartis. Learn more at drugdev.com.